Vir Biotechnology Q3 EPS $(4.6) Down From $(4.16) YoY, Sales $1.4M Down From $2.9M YoY

Vir Biotechnology (NASDAQ:VIR) reported quarterly losses of $(4.6) per share. This is a 10.58 percent decrease over losses of $(4.16) per share from the same period last year. The company reported $1.4 million in sales

Benzinga · 11/19/2019 21:16

Vir Biotechnology (NASDAQ:VIR) reported quarterly losses of $(4.6) per share. This is a 10.58 percent decrease over losses of $(4.16) per share from the same period last year. The company reported $1.4 million in sales this quarter. This is a 51.72 percent decrease over sales of $2.9 million the same period last year.